The Africa Centres for Disease Control and Prevention (Africa CDC) has announced the appointment of Professor Yemi Osinbajo, former Vice President of Nigeria, as Senior Strategic Advisor to its Director General. The appointment, formalized in a statement issued by the agency’s Communications Directorate, marks a significant addition to the continent’s premier public health leadership.
In this high-level role, Osinbajo will provide strategic guidance on critical areas including Africa’s positioning in global health reforms, health financing, local manufacturing of medical commodities, and fostering partnerships. Director General Dr. Jean Kaseya emphasized that Osinbajo’s extensive experience in governance and policy will be invaluable to the agency’s mission. Osinbajo’s tenure as Nigeria’s Vice President from 2015 to 2023 was marked by his chairmanship of the Economic Sustainability Committee and leadership of major business environment reforms. His governance background is seen as essential for navigating complex continental health policies, even as entities like the EFCC arraigns intermediate officers in other sectors for malpractice.
The Africa CDC, as the African Union’s health agency, is central to strengthening continental health systems and emergency response. Its work, such as allocating funds to strengthen National Public Health Institutes, is crucial for sustainable development, a priority as Nigeria launches AfCFTA implementation to boost intra-African trade. The agency’s funding landscape, which recently saw contributions from international partners, remains a key focus for ensuring health security across member states.
This appointment aligns with Osinbajo’s continued engagement in continental development and follows other notable roles, including positions with the United Nations Development Programme. His advisory capacity is expected to bolster Africa CDC’s efforts in building resilient health infrastructure, a foundational element for economic stability and growth, much like the detailed financial disclosures required when a firm such as UACN reports unaudited results to stakeholders. The move underscores the intersection of robust health governance and broader socio-economic progress in Africa.
